Mauna Kea Technologies announced that its joint venture with Tasly Pharmaceutical, Tasly Mauna Kea Medical Engineering Technology, has successfully obtained the Class II Medical Device Business License in China. The Class II classification by China'sNational Medical Products Administration (NMPA) applies to medical devices that require rigorous control and management to ensure safety and efficacy. This business license, issued by the Shanghai Municipal Medical Products Administration, authorizes Tasly Mauna Kea medical Engineering Technology to engage in the wholesale distribution of Class II medical devices across China.